Regenstrief Research Scientist Malaz Boustani, M.D., MPH, described the use of machine learning-powered passive digital markers to detect at an earlier stage people in the U.S. healthcare system at risk for Alzheimer’s disease and related dementias. Between 50 and 80 percent of dementia cases go unnoticed.
-
Research
- Experts
In The News
View AllMedicalXpress quoted Dr. Eric Vachon
Eric Vachon, PhD, R.N., was quoted in MedicalXpress about his...
Influence
View AllMobile Critical Care Recovery Program for Survivors of Acute Respiratory Failure: A Randomized Clinical Trial
Published in JAMA Network Open. Here is a link to...
- Opportunities
Featured Fellowship
View all- About
Regenstrief envisions a world where better information empowers people to end disease and realize true health.
- The Latest
- Experts
February 22, 2023
Dr. Boustani in Clinical Research News
"*" indicates required fields